Average Co-Inventor Count = 3.06
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Roche Sequencing Solutions, Inc. (9 from 277 patents)
2. Roche Molecular Systems, Inc. (1 from 621 patents)
3. Genia Technologies, Inc. (1 from 62 patents)
4. Roche Diagnostics Gmbh (480 patents)
5. F. Hoffmann-la Roche Ag (168 patents)
11 patents:
1. 12416624 - Faradaic systems and methods for self-limiting protein pore insertion in amembrane
2. 12371745 - Use of titanium nitride as an electrode in non-faradaic electrochemical cell
3. 12226766 - Removing and reinserting protein nanopores in a membrane using osmotic imbalance
4. 12123866 - Nanopore sequencing device comprising ruthenium-containing electrodes
5. 12123867 - Systems and methods for self-limiting protein pore insertion in a membrane
6. 11739380 - Counteracting osmotic imbalance in a sequencing cell
7. 11098354 - Use of titanium nitride as an electrode in non-faradaic electrochemical cell
8. 10947590 - Counteracting osmotic imbalance in a sequencing cell
9. 10577653 - Counteracting osmotic imbalance in a sequencing cell
10. 10371664 - Use of titanium nitride as a counter electrode
11. 10174371 - Use of titanium nitride as an electrode in non-faradaic electrochemical cell